Metraipolis › archive › dc_8d45f6151f28
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants — Europe PMC PMID:37880298
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/37880298
- DOI
- 10.1038/s41541-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T14:37:49.656Z
- SHA-256 of the archived text
b0b6d0cf9338370979e9b0672db56bfc986587eb5108114a0acda1345cd97808- Stable URL of this page
https://metraipolis.com/documento/dc_8d45f6151f28
How to cite
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants — Europe PMC PMID:37880298 — Europe PMC (en), https://europepmc.org/article/MED/37880298 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d45f6151f28 (Metraipolis archive dc_8d45f6151f28, sha256 b0b6d0cf9338370979e9b0672db56bfc986587eb5108114a0acda1345cd97808)
BibTeX
@misc{dc8d45f6151f28,
title = {Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants — Europe PMC PMID:37880298},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/37880298},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d45f6151f28; sha256 b0b6d0cf9338370979e9b0672db56bfc986587eb5108114a0acda1345cd97808},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37880298. Agents can read the archived copy with the MCP tool read_document.